Hit clustering can improve virtual fragment screening: CDK2 and PARP1 case studies

作者: Alexey A. Zeifman , Victor S. Stroylov , Fedor N. Novikov , Oleg V. Stroganov , Alexandra L. Zakharenko

DOI: 10.1007/S00894-011-1280-4

关键词: Small Molecule LibrariesIn silicoProtein structureDocking (molecular)Virtual screeningLead FinderCluster analysisCombinatorial chemistryComputer scienceProtein Data Bank (RCSB PDB)

摘要: Virtual fragment screening could be a promising alternative to existing experimental techniques. However, reliable methods of in silico are yet established and validated. In order develop such an approach we first checked how successful the molecular docking can predicting binding affinities poses. Using our Lead Finder software RMSD energy prediction was observed 1.35 kcal/mol−1 on set 26 experimentally characterized inhibitors, predicted pose from one <1.5 A. Then, explored 68 fragments obtained 39 drug molecules for which co-crystal structures were available PDB. It appeared that participate oriented non-covalent interactions, as hydrogen bonds metal coordination, correctly docked 70-80% cases suggesting potential success rediscovering corresponding drugs by approach. Based these findings we’ve developed virtual technique involved structural filtration protein-ligand complexes specific interactions subsequent clustering minimize number preferable starting candidates. Application this method led 2 millimolar-scale PARP1 inhibitors with new scaffold.

参考文章(57)
M Banasik, H Komura, M Shimoyama, K Ueda, Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. Journal of Biological Chemistry. ,vol. 267, pp. 1569- 1575 ,(1992) , 10.1016/S0021-9258(18)45983-2
Wen-Ting Zhang, Jin-Lan Ruan, Peng-Fei Wu, Feng-Chao Jiang, Li−Na Zhang, Wei Fang, Xiang-Long Chen, Yue Wang, Bao-Shuai Cao, Gang-Ying Chen, Yi-Jing Zhu, Jun Gu, Jian-Guo Chen, Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors. Journal of Medicinal Chemistry. ,vol. 52, pp. 718- 725 ,(2009) , 10.1021/JM800902T
Fedor N. Novikov, Viktor S. Stroylov, Oleg V. Stroganov, Ghermes G. Chilov, Improving performance of docking-based virtual screening by structural filtration. Journal of Molecular Modeling. ,vol. 16, pp. 1223- 1230 ,(2010) , 10.1007/S00894-009-0633-8
Zhonghua Pei, Xiaofeng Li, Thomas W. von Geldern, David J. Madar, Kenton Longenecker, Hong Yong, Thomas H. Lubben, Kent D. Stewart, Bradley A. Zinker, Bradley J. Backes, Andrew S. Judd, Mathew Mulhern, Stephen J. Ballaron, Michael A. Stashko, Amanda K. Mika, David W. A. Beno, Glenn A. Reinhart, Ryan M. Fryer, Lee C. Preusser, Anita J. Kempf-Grote, Hing L. Sham, James M. Trevillyan, Discovery of ((4R,5S)-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Journal of Medicinal Chemistry. ,vol. 49, pp. 6439- 6442 ,(2006) , 10.1021/JM060955D
Alex M. Aronov, Christopher Baker, Guy W. Bemis, Jingrong Cao, Guanjing Chen, Pamella J. Ford, Ursula A. Germann, Jeremy Green, Michael R. Hale, Marc Jacobs, James W. Janetka, Francois Maltais, Gabriel Martinez-Botella, Mark N. Namchuk, Judy Straub, Qing Tang, Xiaoling Xie, Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors. Journal of Medicinal Chemistry. ,vol. 50, pp. 1280- 1287 ,(2007) , 10.1021/JM061381F
S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik, Discovering High-Affinity Ligands for Proteins: SAR by NMR Science. ,vol. 274, pp. 1531- 1534 ,(1996) , 10.1126/SCIENCE.274.5292.1531
Paolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, Gabriella Traquandi, Antonio Longo, Marcella Nesi, Fabrizio Orzi, Claudia Piutti, Pietro Sansonna, Mario Varasi, Alexander Cameron, Anna Vulpetti, Fulvia Roletto, Rachele Alzani, Marina Ciomei, Clara Albanese, Wilma Pastori, Aurelio Marsiglio, Enrico Pesenti, Francesco Fiorentini, Jim R. Bischoff, Ciro Mercurio, 3-Aminopyrazole Inhibitors of Cdk2-Cyclin a as Antitumor Agents. 2. Lead Optimization Journal of Medicinal Chemistry. ,vol. 48, pp. 2944- 2956 ,(2005) , 10.1021/JM0408870
Yuan-Ping Pang, Polly Quiram, Tanya Jelacic, Feng Hong, Stephen Brimijoin, Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase STEPS TOWARD NOVEL DRUGS FOR TREATING ALZHEIMER'S DISEASE Journal of Biological Chemistry. ,vol. 271, pp. 23646- 23649 ,(1996) , 10.1074/JBC.271.39.23646
Dominique Lesuisse, Gudrun Lange, Pierre Deprez, Didier Bénard, Bernard Schoot, Georges Delettre, Jean-Pierre Marquette, Pierre Broto, Véronique Jean-Baptiste, Paulette Bichet, Edoardo Sarubbi, Eliane Mandine, SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2. Journal of Medicinal Chemistry. ,vol. 45, pp. 2379- 2387 ,(2002) , 10.1021/JM010927P
Sean C Semple, Arcadio Chonn, Pieter R Cullis, Interactions of liposomes and lipid-based carrier systems with blood proteins : Relation to clearance behaviour in vivo Advanced Drug Delivery Reviews. ,vol. 32, pp. 3- 17 ,(1998) , 10.1016/S0169-409X(97)00128-2